Novel regulations of the angiotensin II receptor type 1 by calmodulin

被引:6
|
作者
Ehlers, Kevin [1 ]
Clements, Robert [1 ]
VerMeer, Mark [1 ]
Giles, Jennifer [1 ]
Tran, Quang-Kim [1 ]
机构
[1] Des Moines Univ, Osteopath Med Ctr, Dept Physiol & Pharmacol, 3200 Grand Ave,Ryan Hall 258, Des Moines, IA 50312 USA
基金
美国国家卫生研究院;
关键词
Angiotensin II receptor type 1; Calmodulin; Calcium; FRET biosensor; Angiotensin II; SMOOTH-MUSCLE-CELLS; PLASMA-MEMBRANE; BINDING; PROTEINS; NETWORK; PHOSPHORYLATION; INTERACTS; DOMAINS; SYSTEM; KINASE;
D O I
10.1016/j.bcp.2018.03.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The angiotensin II receptor type 1 (AT(1)R) mediates many Ca2+-dependent actions of angiotensin II (AngII). Calmodulin (CaM) is a key transducer of Ca2+ signals in cells. Two locations on the receptor's submembrane domains (SMD) 3 and 4 are known to interact with CaM. However, the binding sites for CaM, biochemical properties of the interactions, and their functional impact are not fully understood. Using a FRET-based screening method, we identified a new binding site for CaM on SMD2 (a.a. 125-141), in addition to SMD3 and the juxtamembranous region of SMD4 (SMD4(JM), a.a., 309-327). Simultaneous measurements of CaM binding and free Ca2+ show that the interactions are Ca2+-dependent, with disparate K-d and EC50(Ca2+) values within the physiological range of cytoplasmic Ca2+. Full interaction between CaM and SMD3 requires the entire domain (a.a. 215-242) and has an EC50(Ca2+) value in the range of resting cytoplasmic Ca2+, suggesting AT(1)R-CaM interaction can occur in resting conditions in cells. AngII induces robust ERK1/2 phosphorylation in primary vascular smooth muscle cells. This effect is suppressed by AT(1)R inhibitor losartan and virtually abolished by CaM antagonist W-7. AngII-induced ERK1/2 phosphorylation is suppressed in cells expressing mutant AT(1)R with reduced CaM binding at each identified binding domain. AngII triggers transient Ca2+ signals in cells expressing wild-type AT(1)R. These signals are reduced in cells expressing mutant AT(1)R with reduced CaM binding at SMD3 or SMD4(JM), but are very slow-rising, low amplitude signal in cells expressing AT(1)R. with reduced CaM binding at SMD2. The data indicate that CaM interactions with AT(1)R can occur at various domains, with different affinities, at different physiological Ca2+ levels, and are important for AT(1)R-mediated signaling.
引用
收藏
页码:187 / 200
页数:14
相关论文
共 50 条
  • [21] Advances in the allostery of angiotensin II type 1 receptor
    Xi Zhang
    Suli Zhang
    Meili Wang
    Hao Chen
    Huirong Liu
    Cell & Bioscience, 13
  • [22] Biased Agonism of the Angiotensin II Type 1 Receptor
    Godin, C. M.
    Ferguson, S. S. G.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 812 - 816
  • [23] A novel mechanism of mechanical stress-induced angiotensin II type 1–receptor activation without the involvement of angiotensin II
    Noritaka Yasuda
    Hiroshi Akazawa
    Yingjie Qin
    Yunzeng Zou
    Issei Komuro
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377 : 393 - 399
  • [24] Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice
    Wu, L
    Iwai, M
    Nakagami, H
    Chen, R
    Suzuki, J
    Akishita, M
    de Gasparo, M
    Horiuchi, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) : 49 - 54
  • [25] Angiotensin-(1–1) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor
    Yanping Liu
    Bin Li
    Ximing Wang
    Guishuang Li
    Rui Shang
    Jianmin Yang
    Jiali Wang
    Meng Zhang
    Yuguo Chen
    Yun Zhang
    Cheng Zhang
    Panpan Hao
    Molecular Medicine, 2015, 21 : 626 - 636
  • [26] Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent
    Yang, Rui
    Smolders, Ilse
    Vanderheyden, Patrick
    Demaegdt, Heidi
    Van Eeckhaut, Ann
    Vauquelin, Georges
    Lukaszuk, Aneta
    Tourwe, Dirk
    Chai, Siew Yeen
    Albiston, Anthony L.
    Nahmias, Clara
    Walther, Thomas
    Dupont, Alain G.
    HYPERTENSION, 2011, 57 (05) : 956 - U186
  • [27] Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: Comparison with other angiotensin II type 1 receptor blockers
    Kakuta, H
    Sudoh, K
    Sasamata, M
    Yamagishi, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (01) : 41 - 46
  • [28] Characterization and Functional Effects of Multi-site Interactions between calmodulin and the angiotensin II receptor type 1A
    Clements, Robert
    Ehlers, Kevin
    VerMeer, Mark
    Kim Tran
    FASEB JOURNAL, 2016, 30
  • [29] Chronic angiotensin II infusion suppresses renal expression of angiotensin II type 1 receptor-interacting molecule ATRAP to decrease angiotensin II type 1 receptor internalization
    Tamura, Kouichi
    Wakui, Hiromichi
    Matsuda, Miyuki
    Dejima, Toru
    Shigenaga, Atsu-ichiro
    Masuda, Shin-ichiro
    Azuma, Koichi
    Maeda, Akinobu
    Kanaoka, Tomohiko
    Ohsawa, Masato
    Hirose, Tomonori
    Ishigami, Tomoaki
    Toya, Yoshiyuki
    Yabana, Machiko
    Umemura, Satoshi
    ENDOCRINE JOURNAL, 2010, 57 : S558 - S558
  • [30] The angiotensin II type 1 receptor and receptor-associated proteins
    Guo, DF
    Sun, YL
    Hamet, P
    Inagami, T
    CELL RESEARCH, 2001, 11 (03) : 165 - 180